申请人:Glactone Pharma Development AB
公开号:US20170015644A1
公开(公告)日:2017-01-19
Prodrugs (I) and (Ia) of galiellactone, and derivatives thereof, are provided by reacting the parent compound, e.g. galiellactone, with a thiol. Such drugs may be administered orally to treat cancer and other proliferative diseases.